US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 5.140
  • +0.160+3.21%
Close Dec 20 16:00 ET
  • 5.140
  • 0.0000.00%
Post 16:13 ET
285.75MMarket Cap-2.78P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Foghorn Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 5.450M --
-- 2024/Q4 -- / 8.136M --
-- 2024/Q3 7.808M / 7.010M --
-- 2024/Q2 6.888M / 6.726M --
-- 2024/Q1 5.050M / 7.352M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 5.450M--
--2024/Q4-- / 8.136M--
--2024/Q37.808M / 7.010M--
--2024/Q26.888M / 6.726M--
--2024/Q15.050M / 7.352M--

Unlock Free Earnings Estimates

Foghorn Therapeutics Earnings Reports

  • Foghorn Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 5 05:22

  • Foghorn Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 19:09

  • Foghorn Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 6 19:08

  • Foghorn Therapeutics | 10-K: FY2023 Annual Report

    Mar 7 20:14

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 17, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data